Liabilities, Current of BIO-RAD LABORATORIES, INC. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
BIO-RAD LABORATORIES, INC. quarterly Liabilities, Current in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • BIO-RAD LABORATORIES, INC. Liabilities, Current for the quarter ending 30 Sep 2025 was $522,300,000, a 4.9% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $522,300,000 +$24,357,000 +4.9% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $548,900,000 +$61,939,000 +13% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $506,600,000 +$40,446,000 +8.7% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $467,800,000 -$55,000,000 -11% 31 Dec 2024 10-Q 29 Oct 2025 2025 Q3
Q3 2024 $497,943,000 -$60,233,000 -11% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $486,961,000 -$95,021,000 -16% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $466,154,000 -$123,469,000 -21% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $522,800,000 -$45,908,000 -8.1% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $558,176,000 -$12,501,000 -2.2% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $581,982,000 -$31,732,000 -5.2% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $589,623,000 -$58,708,000 -9.1% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $568,708,000 -$112,230,000 -16% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q3 2022 $570,677,000 -$79,239,000 -12% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $613,714,000 +$26,662,000 +4.5% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $648,331,000 +$38,439,000 +6.3% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $680,938,000 +$49,402,000 +7.8% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q3 2021 $649,916,000 -$336,741,000 -34% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $587,052,000 -$339,843,000 -37% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $609,892,000 -$259,362,000 -30% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $631,536,000 -$273,959,000 -30% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 $986,657,000 +$552,617,000 +127% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $926,895,000 +$480,918,000 +108% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $869,254,000 +$424,948,000 +96% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $905,495,000 +$454,700,000 +101% 31 Dec 2019 10-K 16 Feb 2021 2020 FY
Q3 2019 $434,040,000 -$19,119,000 -4.2% 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $445,977,000 +$3,556,000 +0.8% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $444,306,000 -$11,892,000 -2.6% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $450,795,000 -$51,901,000 -10% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $453,159,000 -$13,297,000 -2.9% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 $442,421,000 -$12,689,000 -2.8% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $456,198,000 +$48,694,000 +12% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $502,696,000 +$31,374,000 +6.7% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $466,456,000 +$23,738,000 +5.4% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $455,110,000 +$44,705,000 +11% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $407,504,000 +$6,616,000 +1.6% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $471,322,000 +$29,971,000 +6.8% 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q3 2016 $442,718,000 +$7,483,000 +1.7% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $410,405,000 +$6,511,000 +1.6% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 $400,888,000 -$15,994,000 -3.8% 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 $441,351,000 -$5,410,000 -1.2% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $435,235,000 -$68,548,000 -14% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $403,894,000 -$76,354,000 -16% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 $416,882,000 -$64,369,000 -13% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 $446,761,000 -$40,711,000 -8.4% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 $503,783,000 +$40,898,000 +8.8% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $480,248,000 +$49,004,000 +11% 30 Jun 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 $481,251,000 +$34,511,000 +7.7% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $487,472,000 +$15,072,000 +3.2% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 $462,885,000 +$29,219,000 +6.7% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $431,244,000 +$14,060,000 +3.4% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $446,740,000 +$2,660,000 +0.6% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 $472,400,000 +$13,285,000 +2.9% 31 Dec 2012 10-K 18 Mar 2014 2013 FY
Q3 2012 $433,666,000 +$18,340,000 +4.4% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 $417,184,000 -$25,660,000 -5.8% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $444,080,000 +$16,489,000 +3.9% 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 $459,115,000 -$207,512,000 -31% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q3 2011 $415,326,000 +$4,632,000 +1.1% 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 $442,844,000 +$53,349,000 +14% 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q1 2011 $427,591,000 31 Mar 2011 10-Q 06 May 2011 2011 Q1
Q4 2010 $666,627,000 31 Dec 2010 10-K 29 Feb 2012 2011 FY
Q3 2010 $410,694,000 30 Sep 2010 10-Q 09 Nov 2010 2010 Q3
Q2 2010 $389,495,000 30 Jun 2010 10-Q 06 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.